
According to Validea's guru fundamental report, AbbVie (ABBV) receives a 93% rating based on their Multi-Factor Investor model, which is based on the investment strategy of Pim van Vliet and favors low volatility stocks with strong momentum and high net payout yields; a score above 90% typically indicates strong interest. The report indicates AbbVie passes the model's market cap and standard deviation tests, while receiving a neutral rating for twelve minus one momentum and net payout yield.
AbbVie Inc. (ABBV) has achieved a notable 93% rating from Validea's Multi-Factor Investor model, which is based on Pim van Vliet's published strategy, indicating strong interest according to the model's criteria where scores above 90% signify such. This quantitative strategy specifically seeks large-cap, low volatility stocks that also possess strong momentum and high net payout yields. ABBV, identified as a large-cap growth stock within the Biotechnology & Drugs industry, successfully passed the model's tests for Market Cap and Standard Deviation, aligning with the low volatility preference. However, the stock received neutral ratings for both 'Twelve Minus One Momentum' and 'Net Payout Yield,' suggesting these specific factors are not currently primary drivers of its high score but are not detrimental enough to prevent a 'PASS' on the final rank. The overall sentiment associated with this report is 'strongly positive' (sentiment score 0.65) and carries an 'optimistic' tone, with the per-ticker sentiment for ABBV being particularly high at 0.8.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.65
Ticker Sentiment